Metalloproteins account for nearly half of all proteins in nature. Protein metal-binding sites are responsible for catalysing important biological processes, such as photosynthesis, respiration, water oxidation, molecular oxygen reduction and nitrogen fixation. Much effort has been devoted to understanding the structure and function of metalloproteins, as summarized by other reviews in this Insight. The ultimate test is to use this knowledge to design new metalloproteins that reproduce the structures and functions of native metalloproteins [1] [2] [3] . Metalloprotein design is not just an intellectual exercise that duplicates biochemical and biophysical studies of native metalloproteins. This 'bottom-up' approach can also elucidate structural features that may remain hidden in those studies. Whereas biochemical and biophysical studies mostly reveal individual features that result in a loss of function, design requires the incorporation of all the structural features needed to attain a function. Equipped with insights from design processes, it may be possible to design new metalloproteins with improved properties such as higher stability and greater efficiency, or to impart them with functions not found in nature, for use in an even wider range of biotechnological and pharmaceutical applications.
Metalloproteins account for nearly half of all proteins in nature. Protein metal-binding sites are responsible for catalysing important biological processes, such as photosynthesis, respiration, water oxidation, molecular oxygen reduction and nitrogen fixation. Much effort has been devoted to understanding the structure and function of metalloproteins, as summarized by other reviews in this Insight. The ultimate test is to use this knowledge to design new metalloproteins that reproduce the structures and functions of native metalloproteins [1] [2] [3] . Metalloprotein design is not just an intellectual exercise that duplicates biochemical and biophysical studies of native metalloproteins. This 'bottom-up' approach can also elucidate structural features that may remain hidden in those studies. Whereas biochemical and biophysical studies mostly reveal individual features that result in a loss of function, design requires the incorporation of all the structural features needed to attain a function. Equipped with insights from design processes, it may be possible to design new metalloproteins with improved properties such as higher stability and greater efficiency, or to impart them with functions not found in nature, for use in an even wider range of biotechnological and pharmaceutical applications.
Metalloprotein design, however, has proven to be more challenging than the design of non-metalloproteins. Both fields require the issue of polypeptide design to be addressed, but metalloprotein design involves metal ions, which are much larger in number than amino acids, and geometries that are much more variable. Conversely, most metal-binding sites are highly chromatic and display distinctive magnetic properties, making it easier to characterize the designed metalloprotein using metal-based spectroscopic techniques rather than X-ray crystallography or nuclear magnetic resonance (NMR), thus shortening design cycles. Therefore, the field of metalloprotein design has enjoyed much success recently, owing to advances in biophysical, computational and structural biology. The field is also progressing from purely structural to more functional designs, and from the design of the primary coordination sphere to that of the secondary coordination sphere and beyond. We summarize these advances here, with a focus on creating new and functional metal-binding sites in either de novo-designed or native protein scaffolds. In addition, the emerging area of designing novel metalloproteins with functions enhanced beyond those available in nature, through the introduction of unnatural amino acids or non-native metal cofactors, is covered. We also summarize the methodologies used in achieving these goals.
Metalloprotein design in de novo-designed scaffolds
The purest and most challenging form of metalloprotein design is de novo design, or design 'from scratch' . De novo design of a metalloprotein involves constructing a polypeptide sequence that is not directly related to any natural protein and that folds precisely into a defined threedimensional structure that binds a metal ion 4 . Most work in this area has focused on introducing metal-binding sites into designed α-helical bundles ( Fig. 1) , which are among the first de novo-designed proteins 4 . These α-helical bundles are a common scaffold for a number of haem proteins in nature. Therefore, not surprisingly, haem centres were among the first, and are some of the most common, metal centres incorporated into de novo α-helical bundles 5 , from mono-haem binding 6 ( Fig. 1a ) to multi-haem maquettes 7 ( Fig. 1b) , mimicking long-range electrontransfer proteins. These proteins were rationally designed by direct comparison with native proteins, such as cytochrome bc 1 , for clues to the placement of essential haem-binding and structure-stabilizing residues. In addition to electron-transfer 8 and proton-coupled exchange 9 functions, a functional aniline hydroxylase 10 , peroxidase 11 and oxygenase 12 have also been engineered into de novo-designed proteins. An exciting development in this field is the design of a di-haem-containing fourhelix bundle with oxygen transport properties, whose O 2 affinities and exchange timescales match those of natural globins 13 . Remarkably, this designed protein binds O 2 even tighter than carbon monoxide, a desirable property that most native O 2 -binding haem proteins do not have. A key to its success is a reduction of helical-interface mobility to exclude water from the haem-binding site, thereby reducing haem oxidation and increasing O 2 -binding stability.
In addition to haem, other metal ions/cofactors have been engineered into helical bundles by introducing metal-binding ligands at specific locations to mimic those in native proteins. Examples are the Cys 2 His 2 ligand set found in zinc-finger proteins 14 and the His 3 set in carbonic anhydrase 15 . The X-ray crystal structure of an arsenic-bound three-stranded coiled-coil protein (Fig. 1c) , which resembles the putative tris-Cys metal-binding environment of the natural arsenic-binding protein, ArsR, has been reported, affording the first biologically relevant thiolate mimic of an AsS 3 coordination 16 . Metal-binding ligands Glu and His have also been introduced by retrostructural analysis, whereby the active site of a protein can be separated into idealized secondary structural components (for example an α-helix and a β-hairpin) and mathematically described as a root-mean-squared deviation from the idealized structure. This strategy led to the construction of dinuclear metalloproteins in α-helical bundles that can bind two Zn(ii), Co(ii) or Fe(ii), with the Zn(ii) crystal structure (Fig. 1d) shown to be structurally analogous to the di-iron site of ribonucleotide reductase and ferritin 17 . One of these di-iron proteins was reported to catalyse a b d c the two-electron oxidation of 4-aminophenol, similar to the reaction catalysed by di-iron phenol oxidases 18, 19 . Motivated by the natural occurrence of Cys-rich coordination sites in proteins, the introduction of Cys ligands led to the development of α-helical coiled-coil metalloproteins capable of binding Co(ii), Fe(ii), Zn(ii), Cd(ii), Hg(ii) and As(iii) [20] [21] [22] . One interesting property of these de novo-designed proteins is that they can stabilize unusual metal-coordination states, for example three-coordinate Hg(ii) stabilized by a trihelical bundle, in preference to more normal coordination states, such as the bis-coordination often preferred by Hg(ii) 23, 24 . In other cases, metal binding can actually direct the folding and assembly of an α-helical bundle from either a random coil or a less-folded or misfolded state, as has been shown for Cd(ii) 25 and Hg(ii) 26 binding to Cys-containing peptides predisposed to form helices. Interestingly, geometry-selective binding of two different Cd(ii) atoms in one designed protein has been achieved and confirmed by the correlation of 113 Cd NMR and 111m
Cd perturbedangular-correlation spectroscopy 27, 28 . In stark contrast to the design of α-helical proteins, de novo design of β-structure proteins is still in its infancy, because there are few model systems with which to study β-sheets in isolation from other protein structures. The de novo design of a redox-active rubredoxin mimic, RM1, is a rare example of a structural and functional metallo-β-sheet protein 29 . RM1 was shown to bind iron and reversibly cycle between the Fe(ii) and Fe(iii) oxidation states, mimicking native rubredoxin. The RM1 β-hairpin structure was designed computationally by constraining the positions of the peptide that were strategic in mimicking and/or stabilizing the β-structure and by subsequently using another computer program, SCADS 30 , to select the most probable amino acids for the remaining positions.
Metalloprotein design in native protein scaffolds
Designing metalloproteins using de novo-designed scaffolds offers the prospect of complete control over a protein's structure and metal-binding properties, but our current knowledge of protein folding limits the number of de novo-designed scaffolds to only a few types, such as the α-helical bundles discussed above. It has been observed that proteins containing β-sheets tend to support more rigid and more pre-organized metal-binding sites than α-helical proteins, which are inherently more flexible 31 . The Protein Data Bank contains many more natural protein scaffold types (~1,000) than it does de novo-designed scaffolds (http:// scop.mrc-lmb.cam.ac.uk/scop/count.html#scop-1.73), and most of the natural protein scaffolds maintain the same fold and are of a similar stability even after numerous mutations. Therefore, metalloprotein design using native protein scaffolds instead of those designed de novo provides many more scaffold choices that are more tolerant to mutations, allowing less concern over decreased protein stability when incorporating metal-binding sites into proteins. When chosen carefully, native proteins are also easier to crystallize than de novo-designed scaffolds, making three-dimensional characterization possible, which is critical to success. Perhaps the strongest argument for designing metalloproteins by using native scaffolds is that nature uses a similar approach -the same scaffold is often seen in numerous proteins with diverse metal-binding motifs and functions, suggesting that these native scaffolds are robust and modifiable. For example, the β-barrel fold has been shown to be used by ~600 types of protein, with diverse functions such as oxidase, reductase, amylase and dismutase activities. Discovering how nature is able to use the same scaffold to design a variety of metal-binding sites is an important goal of metalloprotein design 1 
.
Biochemical techniques, such as site-directed mutagenesis, have been used extensively to study the function of metalloproteins. The loss of function accompanied by certain mutations (usually to highly conserved residues) allows the identification of residues essential for function. Although serving a different purpose, the same mutagenesis techniques can be used in metalloprotein design to impart new function into a protein scaffold by introducing residues that bind metal ions. This can be accomplished through the redesign of existing metal-binding sites to introduce novel functionality, the introduction of mononuclear metal-binding sites into proteins that do not bind metal ions natively, or the introduction of homonuclear or heteronuclear metal-binding sites into proteins. Design is often aided by empirical approaches based on prior knowledge and experience, the use of computer programs (rational design) or combinatorial selections.
The redesign of an existing metal-binding site to introduce new function or metal specificity is the simplest form of metalloprotein design, as this approach relies on the structural differences between template and target proteins and is amenable to empirical approaches as mentioned above. Despite its simplicity, this approach is still powerful in elucidating structural features important for the change in, or gain of, function by redesign. Haem proteins have been extensively redesigned in this way. They are one of the most diverse classes of protein, having functions ranging from electron transfer to smallmolecule (for example oxygen and nitric oxide) transport, sensing and activation 5, 32, 33 . By systematically changing the characteristics of haem proteins, researchers have been able to convert one type of haem protein into another and to introduce new function or substrate specificity into a haem protein [32] [33] [34] . The selectivity of designed metalloproteins for specific metals has also been used for the purpose of metal-sensing applications. Ratiometric Zn(ii) sensors have been created by designing Zn(ii)-binding sites into green fluorescent proteins and by taking advantage of the resultant fluorescent signal variations due to Zn(ii)-dependent conformational changes [35] [36] [37] . The metal-binding site of NikR, a DNA-binding protein, has been redesigned to bind UO 2 2+ rather than its native Ni 2+ cofactor 38 ( Fig. 2a) , resulting in an artificial protein that binds DNA only in the presence of UO 2
2+
. In addition to sensors, designed metal-binding sites have allowed modulation of protein-protein interactions 39, 40 , which are at the heart of many diverse biological functions. Because of complicated non-covalent interactions, it has been difficult to control the protein-protein interactions well. These designed metal-binding sites allow specific control over them.
More complex redesign of metal-binding sites may require rational design using computational biology, such as the simultaneous incorporation and adjustment of functional elements to convert the Gly II enzyme from a glyoxalase, which hydrolyses thioester bonds, to a β-lactamase 41 . In this case, to impart the new functionality, the metalbinding site had to be significantly redesigned to change the metalbinding geometry, as well as the substrate-binding pocket.
Although redesign of metal-binding sites can offer insight into the different structural features possessed by the template and target proteins, it cannot tell us about the structural features common to the metal-binding sites of both proteins. Introducing metal-binding sites into a protein location where no native metal-binding site is found can overcome this limitation, although this approach is more complex. A common strategy is to base the design on structural homology between the template protein (which contains no metal ions) and the target metalloprotein, in order to introduce metal-binding sites into the template protein at the positions corresponding to those in which they are found in the metalloprotein. Using this strategy, new Zn(ii)-binding sites have been introduced into charybdotoxin 42 and retinol-binding protein 43 to mimic carbonic anhydrase. When there is no structural homology, computer-aided design using programs such as METAL-SEARCH 44 and DEZYMER 45 has become indispensable. A Ca(ii) 46 , a Pb(ii) 47 and an [Fe(Cys) 4 ] 45 rubredoxin centre have all been designed into scaffold proteins using computeraided design. In the case of an artificial rubredoxin site designed into the non-metalloprotein thioredoxin, it was found to undergo several rounds of air oxidation and reduction by β-mercaptoethanol, similar to native rubredoxins 45 . Even more difficult in metalloenzyme design is the introduction into proteins of dinuclear metal-binding sites or metal clusters. An example is the binuclear Cu A centre, consisting of two copper ions bridged by two Cys thiolates, with each copper ion also coordinated to a His nitrogen (Fig. 2b) . New Cu A centres were designed into the cupredoxins azurin 48, 49 and amicyanin 50, 51 , using a technique called loop-directed mutagenesis, in which the copper-binding loop of a cupredoxin is replaced by the corresponding loop in cytochrome c oxidase (COX; also known as CcO), which has similar structural homology. Loop-directed mutagenesis has also been used to introduce lanthanide-binding sites into a helix-turn-helix motif by drafting a calcium-binding EF-hand loop, and such a designed protein has been shown to promote DNA and phosphate hydrolysis 52 . Heteronuclear bimetallic centres are also found in many natural proteins, and perform important biological functions such as oxygen reduction, lignin degradation and nitric oxide reduction. Designing metalloproteins to mimic the enzymes that carry out these complex reactions is even more challenging than designing homonuclear metalbinding sites because of the need to selectively place and bind two or more different metal centres. An example is the haem-Cu B centre in COX, where three His molecules bind a Cu(ii) ion that is ~4.5 Å away from the haem centre. Computer-aided design was used to introduce the His molecules above the haem of myoglobin at positions corresponding to those in COX 53 ( Fig. 2c) . Copper binding was confirmed by multiple spectroscopic techniques. Further studies showed the importance of the Cu B site in O 2 binding and reduction, as well as the significance of a proton network 54 . This designed protein also displays interesting functional properties, such as nitric oxide reduction 55 , similar to certain members of the COX family. A Mn(ii)-binding site has also been designed into cytochrome c peroxidase, resulting in a haemMn(ii) protein that structurally and functionally mimics manganese peroxidase 56 .
In addition to discrete metal-binding sites, metal nanoparticles have been introduced into proteins 57 , including platinum nanoparticles into ferritin 58 and a small heat-shock protein 59 . The former catalyses size-selective alkene hydrogenation and the latter catalyses hydrogen production.
Although approaches based on empirical knowledge and rational design using computer programs have been relatively successful in designing metalloproteins, it is still difficult to design certain metalloproteins, especially functional ones, owing to the large number of potential interactions within the active site of a metalloenzyme. In this case, combinatorial design and directed evolution of new metalloenzymes is another powerful method. For example, directed evolution has been extensively applied to antibodies to develop new metalloenzymes. Using phage display, the 7G12 antibody protein was evolved to bind specifically to haem, with which the oxidation of tyramine could be catalysed 60 . A similar technique has recently been used to find antibodies specific for inorganic ligands, such as 2,2ʹ-bis(diphenylphosphino)-1,1ʹ-binaphthyl (BINAP) and 1,1ʹ-bi-2-naphthol (BINOL), with the goal of developing completely new metallo enzymes 61 . Another striking example of this approach is the use of directed evolution to obtain a new form of cytochrome P450 with the ability to hydroxylate propane selectively, a function that has not yet been achieved using small-molecule catalysts 62 .
Designing unnatural metalloproteins
Metalloprotein design using de novo-designed or native protein scaffolds has succeeded in providing valuable insights into the fundamental rules that govern protein structure and function. Replicating native protein structure and function, although challenging, is not the only goal of protein designers; they want to build proteins with properties that exceed those found in nature 63 . In recent years, the repertoire of functional groups such as amino acids or cofactors available to protein designers has been expanded beyond that available in biological systems.
A myriad of techniques have been developed for the incorporation of unnatural amino acids into a protein scaffold, each with its own advantages and limitations 63 . Total synthesis of proteins using solid-phase peptide synthesis allows the incorporation of any synthetic amino acid for which successful protection and deprotection techniques can be applied 64 , but cost and size constraints limit the use of total synthesis to smaller proteins (~60-100 amino acids). Native chemical ligation, involving covalent attachment of two synthetic peptides, has expanded this size 65 , but cost is still an issue, at least for very large proteins. Expressed-protein ligation, which involves the coupling of a bacterially expressed peptide fragment with a synthetic peptide fragment containing unnatural amino acids, has reduced the cost and extended the protein size even further, but it often requires a Cys residue at the point of ligation to maximize ligation efficiency 66 (methods have been developed to use other residues at the point of ligation, but with less efficiency). Methods not restricted by protein size include auxotroph generation 67 , chemical residue modification 68 and cavity complementation 69 , but these methods have limited versatility in terms of the variety of unnatural amino acids that can be incorporated. A promising and versatile technique is the use of custom evolved transfer-RNA synthetase molecules for in vitro and in vivo translation of new residues through recognition of the amber stop codon 70 . A major contribution resulting from this approach was the design of a DNA-cleaving protein through site-specific genetic incorporation of the DNA-cleaving agent (2,2ʹ-bipyridin-5-yl)alanine into a DNA-binding protein 71 . On addition of Cu(ii) or Fe(ii) and reducing agent to the protein, a double-stranded DNA substrate was cleaved at its consensus sequence. The variety of unnatural amino acids that this technique can incorporate is greater than that which can be used in auxotroph generation, chemical residue modification or cavity complementation, but less than that which can be used in total synthesis, native chemical ligation or expressed-protein ligation.
The expansion of the amino-acid regime has made significant contributions to the systematic determination of the role of each amino acid in tuning the activity of the metal centre to a given reactivity, and in increasing the breadth of chemical transformations performed by proteins. For instance, replacement of haem-binding His residues in de novo-designed four-α-helical bundles with 4-β-(pyridyl)-l-alanine and 1-methyl-l-histidine has resulted in an increase in the reduction potential of the metal site for the pyridyl system and a preference for five-coordinate low-spin haem in the 1-methyl-l-histidine system 72 . In another system, introduction of bulky penicillamine ligands in place of Cys molecules led to the creation of an open metal-binding site in a ferredoxin model peptide 73 . This methodology resulted in the isolation of the first water-stable CdS 3 complex through subtle manipulation of steric crowding around the metal centre 74 . Furthermore, substitution of l-amino acids for their d-enantiomers resulted in fine control between three-and four-coordinate Cd(ii) complexes in a de novodesigned metallopeptide 75 . Finally, the role of a conserved Tyr residue near the active site of rubredoxin was probed using a set of unnatural Tyr analogues in which the para -OH group was replaced with -H (as in native Phe), -F, -CN and -NO 2 groups, spanning a range of electron withdrawing strengths 76 (Fig. 3a) . Interestingly, a linear correlation was found between the reduction potential of the rubredoxin and the Hammett σ p value, but no such trend was observed with dipole moment or para-substituent size.
A powerful advantage of introducing unnatural amino acids is the ability to probe the role of the amide backbone, because site-directed mutagenesis using natural amino acids cannot modify the protein backbone. Both the carbonyl and nitrogen functionalities of the protein backbone have been implicated in critical and specific hydrogenbonding interactions, either directly to the metal or to the metal ligands. For example, the Fe 4 S 4 cluster of high-potential iron proteins has such an amide interaction, which was found to be responsible for stabilizing the reduced form through attenuation of a metal-bound sulphur 77 . Replacement of this amide linkage with an ester linkage indeed resulted in a lowering of the reduction potential by ~100 mV.
Through the use of expressed-protein ligation, the metal-bound Cys and Met residues in the electron-transfer protein azurin were replaced with isostructurally similar unnatural amino acids 78, 79 (Fig. 3b) . Replacing Cys with selenocysteine resulted in significantly different spectral features, but did little to affect the reduction potential. By contrast, replacing methionine with selenomethionine and other isostructural variants resulted in spectral features similar to those of the wild-type protein, but with significantly different reduction potentials. The use of unnatural amino acids helped to identify the hydrophobicity of the residues at this position as the major factor in tuning the reduction potential of the protein, resulting in new metalloproteins with reduction potentials beyond those found in native azurin and its variants.
The repertoire of non-native functionalities has also been expanded through the incorporation into the protein scaffold of metal-containing cofactors not found in nature. Biological systems incorporate metal cofactors such as haem by both non-covalent and covalent means. Of the covalent approaches in nature, both single-point and dual-point anchoring strategies are used to position the prosthetic group within the protein scaffold. These strategies have been used for the incorporation of non-native metal cofactors, with the non-covalent approach being the most extensively used strategy. For example, replacement of the native haem cofactor in myoglobin with less symmetrical structural isomers such as porphycene (Fig. 4a ) has resulted in new or enhanced O 2 -binding affinity or O 2 -activation activities [80] [81] [82] . In addition to native protein scaffolds, de novo-designed α-helical bundles have also been engineered to bind non-biological haem cofactors in preference to biological haems 83, 84 . In addition to haem analogues, other planar moieties similar to haem have been substituted into haem proteins. For example, strong binding of manganese, iron and chromium Schiff-base complexes into a myoglobin scaffold was observed after careful design of the protein to relieve steric repulsion in the active site 57, 85, 86 (Fig. 4b) . Such rational design has resulted in new asymmetrical catalysts capable of oxidationrate enhancement and chiral induction.
It is much more challenging to incorporate non-planar metal-containing cofactors into proteins in which there is no native binding site. One way to do so is through derivatization of the catalyst with a moiety exhibiting natural bio-affinity for a protein target, through, for example, the use of the high-affinity biotin-streptavidin couple (association constant, K a = ~ 10 15 M −1
). In this way, metal cofactors such as a ruthenium catalyst have been incorporated into the streptavidin scaffold through covalent attachment to a biotin moiety [87] [88] [89] (Fig. 4c) , resulting in artificial biocatalysts with new activities, including hydrogenation of alkenes, transfer hydrogenation of ketones, and carbon-carbon bond formation through allylic alkylation (with up to 99% enantiomeric excess) [88] [89] [90] [91] . Although the use of biotin and avidin/streptavidin to incorporate non-native metal cofactors is powerful, not all cofactors are amenable to such a strategy, as binding affinity and location may not be readily controlled. Covalent attachment is an effective and versatile method for linking a cofactor to the protein at a defined location through selective conjugation techniques involving engineered or native Cys or Lys residues. This strategy has been used to attach DNA-cleaving agents such as 1,10-phenanthroline-copper and iron-EDTA to DNA-binding proteins for the generation of artificial nucleases 92 , and in the case of 1,10-phenanthroline-copper (Fig. 4d) for enantioselective hydrolysis 93, 94 . The single-point covalent approach mentioned above makes it possible to attach a non-native cofactor at a defined location, but it does not necessarily fix the conformation of the cofactor inside the protein.
For example, single covalent attachment of a 4-(2-methanesulphonylthio-ethoxy)salicylidene-1,2-ethanediamino-manganese(iii) (Mnsalen) cofactor to apo myoglobin through a single Cys-selective linker resulted in only 12% enantiomeric excess towards sulphoxidation of thioanisole 95 , suggesting that the Mn-salen conformation may be too flexible inside myoglobin to facilitate high enantioselectivity. Addition of a second linker (Fig. 4e) to the cofactor together with selective cavity positioning led to a significant increase in catalytic efficiency (more than a sevenfold increase) and enantioselectivity (increased from 12% to 88%) 95, 96 . Furthermore, it has been shown that such incorporation of Mn-salen into a myoglobin scaffold significantly enhances the chemoselectivity in oxidation of thioanisole with H 2 O 2 , almost eliminating over-oxidation to the sulphone product through electrostatic exclusion of the sulphoxide product from the site 96 .
Lessons learned and future challenges
Tremendous progress has been made in this exciting field of synthetic biology. Success is measured not only by how closely the designed protein resembles the native protein, but also by the insights gained from the process. For example, the crystal structure of a designed Cu A site is almost identical to that of native Cu A , including both primary and secondary coordination spheres 49 (Fig. 5) , indicating that metalloprotein design can lead to structures closely resembling those in nature. More importantly, two metal-binding sites, native blue copper and the designed Cu A centre, were placed in the same azurin scaffold, allowing the electron-transfer properties of two different metal centres to be compared in the same protein 97 -a task that is difficult, if not impossible, to do by studying native proteins. Such a comparison provided deeper insight that the Cu A centre is a more efficient electron-transfer centre than the blue copper centre 97 . Given the initial successes, now is a good time to summarize the lessons learned and to recognize future challenges. Essential to success is the recognition that structural biology must have a major role in the design process. Some early metalloprotein designs generated much excitement in the field, only to be shown by X-ray crystallography to contain a different metal-binding site than originally designed. Although spectroscopy is invaluable in providing support for design, more concrete evidence from three-dimensional structural characterization is essential. In addition to confirming the initial design, it provides detailed information on what has or has not been designed correctly, thus providing insights for the next level of design.
Furthermore, design of the primary coordination sphere is often not enough to confer structure and/or function. Consideration of the environment surrounding the primary coordination sphere is critical to successful design. One main example is water molecules found at specific locations inside the protein, where the associated hydrogen-bonding interactions have essential roles in many metalloproteins, including cytochrome P450, haem oxygenase (HO) and COX 33 . For example, even though a Cu B centre that structurally mimics the haem-copper centre in COX was designed into myoglobin 53 , its function mimics HO rather than COX when O 2 is used as an oxidant 54 . When H 2 O 2 was used as an oxidant, a ferryl species, a putative intermediate in COX activity, was observed. These results suggest that the extra protons introduced through H 2 O 2 are important for function 54 . The introduction of an additional hydrogen-bonding donor through the replacement of the type-b haem in myoglobin with a type-o haem, resembling the haem found in COX, allowed suppression of HO activity and promotion of COX activity 98 . Metalloprotein design has focused mainly on the positive design of structural features responsible for correct metal-site geometry and function. However, negative design to prevent competing metal-site geometries and unwanted functions is also critical. For example, in designing dinuclear metalloproteins in a helical bundle, there was a possibility that undesirable heterotetrameric motifs and homooligo mers would form because the protein comprised different peptides. To circumvent this problem, a computational algorithm was included to destabilize these interactions 99 . The final lesson is that metalloprotein design often results in lower stability because of changes made to the protein scaffold. Sometimes, the stability is so low that even if the design is valid, not enough stable protein can be obtained to prove the design. The stability of the protein must be improved, even if function may not be improved directly. A good example of this was demonstrated in cytochrome P450: only after the protein was stabilized by further mutations could the initial design confer new activity 100 . The majority of the successes in the field of metalloprotein design are derived from the construction of a geometrically correct, sterically compatible primary coordination sphere sufficient to reproduce the structure and function of a desired metal centre, such as a bis-histidine haem or His 2 Cys 2 tetrahedral Zn(ii) site. However, many metal-binding sites in proteins, such as the type-1 copper and Cu A centres, are not necessarily in their preferred metal-ion geometric states. Therefore, one future challenge is to design metal sites and metal clusters with unique geometric requirements. Other challenges include the design of metal sites at the interface of two or more proteins, which occur often in proteins but have not been designed until recently 39, 40 , and the design of metal-binding sites from membrane proteins, which has also been rarely achieved. A greater challenge is the design of protein metal-binding sites requiring helpers called metallochaperones. Consideration of the interactions between metal ions and protein hosts is not enough to confer function, making their interactions with metallochaperones necessary in the design process. In addition to metal-binding-site design, functional metalloproteins also require the design of a substrate-binding site for catalysis. A higher level of complexity involves coupling the redox reaction of a designed metal-binding site to proton transfer, conformational change or charge separation.
To meet these challenges, advances in a number of fields are required. The most important requirement is the development of better computer programs for designing metal-binding sites in proteins, including consideration of structural features beyond the primary coordination sphere. In contrast to well-defined force fields for peptide bonds and aminoacid side chains, most force fields for metal-binding sites are ill-defined because there are many more variables involved in defining a metal-binding site. These variables include variation in the identity of the metal ion, different oxidation states of the same metal ions and different ligand and geometric preferences of different metal ions. Density functional theory has been an excellent tool in defining small metal complexes. Extending its success to metal-binding sites in proteins, together with other leading algorithms, such as QM/MM (quantum mechanics/molecular mechanics), is required for the successful rational design of metalloproteins. Despite these challenges, metalloprotein design will remain a vibrant field in which researchers will continue to design metallo proteins with novel functions and gain new insights. 
